Atlas Trials

Relapsed or Refractory B Cell Non Hodgkin Lymphoma

13 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Relapsed or Refractory B Cell Non Hodgkin Lymphoma

RecordFirmDate
GZL Sequential CD19/CD22 CAR-T in Relapsed or Refractory B-cell Non-Hodgkin Lymphoma (NCT05797948)The First Affiliated Hospital of Soochow University2022-07-01
Study of Capivasertib in Relapsed or Refractory B-cell Non-Hodgkin Lymphoma (NCT05008055)AstraZeneca2021-11-03
CD19 Targeted Universal Chimeric Antigen Receptor T Cells Injection for CD19+ Refractory/Relapsed B-cell Malignancies (NCT05105867)920th Hospital of Joint Logistics Support Force of People's Liberation Army of China2021-09-29
A Study to Evaluate MK-1045 (CN201) in Participants With Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma (MK-1045-001/CN201-101) (NCT06189391)MSD R&D (China) Co., Ltd.2021-03-16
Study of Safety,Efficacy and Pharmacokinetics of CT-1530 in Patients With Relapsed or Refractory B Cell Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, and Waldenstrom's Macroglobulinemia (NCT02981745)Centaurus Biopharma Co., Ltd.2017-04-01
Gene Therapy for B-Cell Non-Hodgkin Lymphoma Using CD19 CAR Gene Transduced T Lymphocytes (NCT02134262)Jichi Medical University2014-05-01

Track Relapsed or Refractory B Cell Non Hodgkin Lymphoma automatically

Every clearance here is in the API, with alerts when new ones post.